J Clin Neurol.  2019 Oct;15(4):572-574. 10.3988/jcn.2019.15.4.572.

Association between the Levofloxacin Plasma Concentration and Neurological Adverse Events in an Elderly Patient

• Kang G
• Min SH
• Kim JK
• Kang KW

• KMID: 2467770
• DOI: http://doi.org/10.3988/jcn.2019.15.4.572

Abstract

No abstract available.

MeSH Terms

Aged*
Humans
Levofloxacin*
Plasma*

Figure

• 

  Fig. 1 Plasma levels of levofloxacin during the clinical course of our patient.

Reference

1. U.S. FDA. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes [Internet]. Silver Spring, MD: U.S. FDA;2018. cited 2018 Jul 10. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side.

2. European Medicines Agency. Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-lasting side effects Share [Internet]. Amsterdam: European Medicines Agency;2018. cited 2018 May 10. Available from: https://www.ema.europa.eu/en/news/fluoroquinolonequinolone-antibiotics-prac-recommends-new-restrictions-use-following-review.

3. Bellon A, Perez-Garcia G, Coverdale JH, Chacko RC. Seizures associated with levofloxacin: case presentation and literature review. Eur J Clin Pharmacol. 2009; 65:959–962.

4. Akahane K, Tsutomi Y, Kimura Y, Kitano Y. Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding. Chemotherapy. 1994; 40:412–417.

5. Tomé AM, Filipe A. Quinolones: review of psychiatric and neurological adverse reactions. Drug Saf. 2011; 34:465–488.

6. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf. 1994; 10:93–102.